1. Zhao Y, Guo MX, Li DD, Xu WY, Pan C, He CR, Cui XL.Pharmacokinetics and Dosing Regimens of Direct Oral Anticoagulants in Morbidly Obese Patients: An Updated Literature Review.Clinical and Applied Thrombosis/Hemostasis.2023.29.1-17.SCI |
2. Zhang ZQ, Zhao Y , Li DD , Guo MX , Li HY , Liu RJ, Cui XL*.Safety, efcacy and prognosis of anticoagulant therapy for portal vein thrombosis in cirrhosis: a retrospective cohort study. Thrombosis Journal .2023.21(13).1-8.SCI |
3. 崔向丽,李泽亚# ,徐烨, 高婷,李丹, 赵峰, 郝晶,杨春磊,宋佳树,顾献忠, 黄榕翀*.社区中老年人群尿酸水平与高血压的 相关性及其性别差异和临界值探讨.中华全科医师杂志.2023.22(3).263-270.核心期刊 |
4. 刘冉佳,张志琪,黄文华,檀玉乐,孙丽莹,朱志军,崔向丽*.肝移植儿童生命质量评估量表的系统综述.药物流行病学杂志.2022.31(4).59-64.核心期刊 |
5. 郭晓龙,崔向丽*,李激扬.头孢他啶/阿维巴坦与碳青霉烯类疗效和安全性比较.中国新药杂志.2022.31(7).97-104.核心期刊 |
6. Guo M, Liang J, Li D,Wang L*, Cui X*.. Coagulation dysfunction events associated with tigecycline: a real-world study from FDA adverse event reporting system (FAERS) database. .Thromb J,2022,20(1):12-19. .2022.20(1).12-19.SCI |
7. 崔向丽,张志琪,孙丽莹,郭明星,曾志贵,徐菀佚.基于FDA不良事件报告系统数据库的来氟米特致肝损伤病例分析.中国药物警戒.2022.19(4).431-436.核心期刊 |
8. Zheng MM, Guo MX#, Shang LM*,Zhang J, Lin J, Tian Y, Cui XL*,Zhu YC*.Effect of Carbapenem-Resistant Klebsiella pneumoniae Infection on the Clinical Outcomes of Kidney Transplant Recipients.Infection and drug resistance.2022.15.6471-6483.SCI |
9. Cui XL, Yan CL, Xu Y, Li DD, Guo MX, Sun LY, Zhu ZJ.Allograft rejection following immune checkpoint inhibitors in solid organ transplant recipients: A safety analysis from a literature review and a pharmacovigilance system.Cancer Medicine.2022.0.1-14.SCI |
10. 崔向丽,王应楷,韩宝峰,张志琪,郭明星,徐菀佚.临床药师参与华法林抗凝教育对肺栓塞患者认知度的影响.中国医院药学杂志.2021.41(8).80-83.核心期刊 |
11. 刘书衡,崔向丽*,张志琪..基于决策树模型的3种药物治疗艰难梭菌感染成本-效果分析..中国药物应用与监测.2021.18(9).346-354.核心期刊 |
12. Guo M, Sydney Thai,Zhou J,Wei J,Zhao Y,Xu W,Wang T*,Cui XL*.Evaluation of rivaroxaban-, apixaban- and dabigatran-associated hemorrhagic events using the fda-adverse event reporting system (FAERS) database.,. International Journal of Clinical Pharmacy.2021.43(6).1508-1515.SCI |
13. 高 婷 ,王晓剑,张 超,郭明星,徐菀佚,崔向丽*.我国药物咨询门诊工作现状分析.中国医院用药评价与分析.2021.21(2).244-246.核心期刊 |
14. 张 鹏,赵 莹,田沛荣,李梦伊,祁子添 ,郝祯 ,刘 洋,刘京丽,崔向丽*,张忠涛*.京津冀晋地区减重与代谢外科围手术期静脉血栓 栓塞症防治现状调查分析.中国实用外科杂志.2021.41(3).81-86.核心期刊 |
15. 曹鑫,孙玉泉,黄贵民,冉仲阳,崔向丽*.他克莫司与伏立康唑联合使用不良反应信号挖掘与分析.中国药物警戒,2021,18(5):483-488..2021.18(5).483-488.核心期刊 |
16. Xuan Di, Muyi Chen, Su Shen, Xiangli Cui *.Antipsychotic use and Risk of Venous Thromboembolism: A Meta-Analysis.Psychiatry Research .2021.296.113691-113698.SCI |
17. Hongtao Wei, Can Cui, Xiangli Cui*, Yi Liu and Dandan Li.Cost‐effectiveness analysis of dabigatran, rivaroxaban and warfarin in the prevention of stroke in patients with atrial fibrillation in China.BMC Health Services Research.2021.21(96).96-105.SCI |
18. 韩宝峰,朱志军,沈素,崔向丽,孙丽莹.肝移植受者免疫抑制药应用的药物经济学研究系统评价.药物流行病学杂志.2021.30(4).35-40.核心期刊 |
19. Tingting Qiu, Peng Men, Xiaohan Xu, Suodi Zhai∗, Xiangli Cui∗.Antiemetic regimen with aprepitant in the prevention of chemotherapy-induced nausea and vomiting.Medicine.2020.99(33).e21559-e21565.SCI |
20. 邱婷婷 ,门鹏 ,程吟楚 ,张晨,刘斌,翟所迪 *,崔向丽*.化疗所致恶心呕吐不同预防方案的非药品次均医疗费用分析.临床药物治疗杂志.2020.18(3).47-51.核心期刊 |
21. 卫红涛 ,崔向丽 *,刘莹 ,李丹丹.临床药师开展药物治疗管理的实践经验与成本-效益分析.中国现代应用药学.2020.37(15).1884-1888.核心期刊 |
22. 王应楷,崔向丽*,侯珂露,马卓,王颖,王鑫.肝素诱导的血小板减少临床病例分析.药物不良反应杂志.2020.21(6).414-419.核心期刊 |
23. 张彩霞,孙瑞芳,马卓,崔向丽*.两种标准分析老年住院患者的潜在不适当用药.中国药事.2020.34(6).700-706.核心期刊 |
24. 郭明星,郭恒,沈素,孙丽莹,崔向丽*.肝功能不全患者伏立康唑血药浓度监测回顾性研究.中国临床药理学与治疗学.2020.7.757-763.核心期刊 |
25. Ying Wang, Zhikang Ye, Lihong Liu, Xiangli Cui* .Antidepressant Use and Risk of Venous Thromboembolism: A .J Pharm Pharm Sci .2019.22.52-71.SCI |
26. Ma Z, Zhang CX, Cui XL*, Liu LH*.Comparison of three criteria for potentially inappropriate medications in Chinese older adults.Clinical Interventions in Aging.2019.14.1-8.SCI |
27. 任洁,崔向丽*, 高业, 岳文静.炔雌醇环丙孕酮片致肺栓塞1例.中国药物警戒.2019.16(5).311-312.核心期刊 |
28. 田艳平,谢婧,刘丽宏,崔向丽*,王霞.2015—2017年首都医科大学附属北京佑安医院保肝类药物的使用情况分析.现代药物与临床..2019.34(2).527-533.核心期刊 |
29. 王应楷,崔向丽*,侯珂露.肝素诱导的血小板减少症临床病例分析.药物不良反应杂志.2019.21(6).414-419.核心期刊 |
30. Xiangli Cui, Zirui Wan, Zhuo Ma, Lihong Liu, Yuanhua Yang .Acute pulmonary embolism occurring during postoperative treatment with recombinant erythropoietin of pure red cell aplasia associated with thymoma: case report.Medicie.2019.98(10).1-4.SCI |
31. 张彩霞,马卓,崔向丽*.三种老年人潜在不适当用药评估标准的比较.中国药物应用与监测.2019.16(1).43-45.核心期刊 |
32. 刘彦会,崔向丽*,崔海洋.1例利伐沙班治疗肝素诱导的血小板减少症的用药分析.临床药物治疗杂志.2018.16(7)).59-61.核心期刊 |
33. Wang Y, Ye ZK, Li JF, Liu LH, Cui XL*.Heparin-induced thrombocytopenia: A critical appraisal of clinical practice guidelines with the AGREE II instrument.Thrombosis Research.2018.166.10-18.SCI |
34. 崔向丽#,侯珂露,杨媛华*.直接口服抗凝药物治疗肝素诱导的血小板减少症临.中国医刊.2018.53(10).1139-1141.核心期刊 |
35. 侯珂露、刘丽宏,崔向丽*.临床药师参与肺栓塞患者抗凝管理的效果评价.中国药学杂志.2018.53(8).88-93.核心期刊 |
36. Hou KL, Yang H, Ye ZK, Wang Y, Liu LH,Cui XL*..Effectiveness of Pharmacist-led Anticoagulation Management on Clinical Outcomes: A Systematic Review and Meta-Analysis.J Pharm Pharm Sci.2017.20.378-396.SCI |
37. 邱 爽,邸 宣,崔向丽*.我院临床药师用药建议评价与分析.中国新药杂志.2017.26(17).2092-2096.核心期刊 |
38. 崔向丽 宋向锋 吕亚丽 叶志康 杨辉 邱爽 刘丽宏*.胸外科患者入院自带药品使用问题.医药导报.2017.36(11).1326-1328.核心期刊 |
39. Hui Yang, Xiangli Cui, Xin Wang, Shuang Qiu, Lihong Liu*.Clinical Outcomes with Antiviral Prophylaxis or Preemptive Therapy .j pharm pharm sic.2017.20(1).15-27.SCI |
40. 崔向丽,王诗卉,李激扬,刘丽宏*,林松.案例教学法在临床药师实习教学中的应用.中国临床药理学.2017.7(26).659-661.核心期刊 |
41. 崔向丽 万子睿 侯珂露 杨辉 于晓佳 郑芸颖 刘丽宏 * 杨媛华.增加肿瘤患者血栓风险的药物概述.中国药物警戒.2017.14(7).430-434.核心期刊 |
42. 王诗卉,崔向丽.头孢西丁和复方甘草口服溶液联用致双硫仑反应.药物不良反应杂志.2017.19(2)).149-150.核心期刊 |
43. 马 卓,崔向丽*,刘丽宏*.精准用药门诊1例低钠血症患者的药物治疗管理.中国新药杂志.2017.26(7).837-840.核心期刊 |
44. Hui Yang, Xiangli Cui, Zhuo Ma, Lihong Liu*.Evaluation Outcomes Associated with Alternative Dosing Strategies for.J Pharm Pharm Sci.2016.19(2)).274-289.SCI |
45. 崔向丽,游宾,胡滨,李辉*,刘丽宏*.肺移植术后免疫抑制剂应用进展.国际呼吸杂志.2016.36(3).228-232.核心期刊 |
46. Zhi-Kang Ye, Ying Liu, Xiang-Li Cui, Li-Hong Liu*.Critical Appraisal of the Quality of Clinical.PLOSONE.2016.5(6).1-9.SCI |
47. 崔向丽,林松,张征,邱爽,刘丽宏*.外科临床药师参与术后抗感染会诊实例分析.中国临床药理学杂志.2015.31(19).1968-1970.核心期刊 |
48. 刘莹,崔向丽,刘丽宏*.国内外药物重整研究进展.中国药学杂志.2015.50(24).2099-2102.核心期刊 |
49. 崔向丽,林松*.神经外科术后颅内感染的诊疗进展.中华神经外科杂志.2014.30(3).312-314.核心期刊 |
50. 崔向丽,刘丽宏* ,李激扬,邱 爽,林 松.利奈唑胺治疗神经外科术后颅内感染疗效分析.中国感染控制杂志.2014.13(5).287-290.核心期刊 |
51. 崔向丽,王颖,邱爽,刘丽宏*.114例注射用赖氨匹林不良反应分析.中国新药杂志.2014.23(14).1717-1720.核心期刊 |
52. 崔向丽,邱爽,司徒伟,赵瑞,王颖,周虹,黄茜,盖迪,刘丽宏*.羟乙基淀粉130/0.4氯化钠注射液应用评价及文献回顾.中国药物警戒.2014.11(6).358-361.核心期刊 |
53. Guo-Bin Zhang#,Xiang-Li Cui# , Da-Li Sui, Xiao-Hui Ren,Zhe Zhang,Zhong-Cheng Wang,Song Lin*.Differential molecular genetic analysis in glioblastoma multiforme Of long- and short-term survivors:a clinical study in Chinese patients.Journal of Neurooncology.2013.113(2).367-375.SCI |
54. Xiangli Cui1,#, Zhiqin Xu#, Zhigang Zhao, Dali Sui1, Xiaohui Ren1, Qiming Huang, Jiazhen Qin,Song Lin*.Analysis of CD137L and IL-17 Expression in Tumor Tissue as Prognostic Indicators for Glioblastoma.International Journal of Biological science.2013.9(2).134-141.SCI |
55. 崔向丽,张长平,高颖昌,刘腾,朱乐亭,赵志刚*,林松*.基于问题学习教学法在临床药学教学中的应用.医药导报.2013.201307.36-38.核心期刊 |
56. 崔向丽,隋大立,贾文清,林松*.胶质母细胞瘤常用化疗方案的疗效和安全性比较 .中华神经外科杂志.2012.28(5).535-539.核心期刊 |
57. 崔向丽,隋大立,李靖, 张宇,史卫忠,赵志刚*.高渗药物使用风险与规避.中国药物警戒.2012.9(4).628-630.核心期刊 |
58. 崔向丽,林松,史卫忠,赵志刚*.临床药师参与神经外科药物治疗实践.中国药学杂志.2012.19(16).1600-1613.核心期刊 |
59. 林松,赵志刚*.大剂量甲氨蝶吟治疗原发性中枢神经系统淋巴瘤的血药浓度监测及不良反应分析.中国临床药理学杂志.2011.27(3).218-222.核心期刊 |